IRD Opus Genetics, Inc.
Opus Genetics, Inc. (IRD) Insider Activity
What the officers, directors and large holders did with their own shares. Only open-market purchases and sales count toward the totals — grants, option exercises and shares withheld for tax are compensation mechanics, not decisions, and they're listed separately below.
How much of that selling was preplanned? 0% planned / 100% discretionary
Largest single sale: $8.6M.
Where they traded
Last open-market purchase: December 29, 2025 , by Gallagher Cam .
Recent open-market activity
| Date | Insider | Role | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|---|
| Gagnon Robert E. | Chief Financial Officer | Sell | 28,000 | $4.54 | $127.2K | 556,375 −4.8% of holding | |
| Magrath George | Chief Executive Officer | Sell | 9,475 | $2.95 | $27.9K | 1,731,869 −0.5% of holding | |
| Gagnon Robert E. | Chief Financial Officer | Sell | 7,783 | $2.95 | $22.9K | 584,375 −1.3% of holding | |
| YERXA BENJAMIN R | President | Sell | 7,429 | $2.97 | $22.1K | 704,106 −1% of holding | |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | 4,644 | $2.94 | $13.7K | 291,440 −1.6% of holding | |
| Sell | 1,700,000 | $4.35 | $7.4M | 3,792,171 −31% of holding | |||
| Magrath George | Chief Executive Officer | Sell | 9,511 | $5.22 | $49.6K | 1,741,344 −0.5% of holding | |
| Gagnon Robert E. | Chief Financial Officer | Sell | 7,842 | $5.18 | $40.7K | 592,158 −1.3% of holding | |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 7,542 | $5.19 | $39.2K | 509,233 −1.5% of holding | |
| YERXA BENJAMIN R | President | Sell | 7,470 | $5.24 | $39.1K | 711,535 −1% of holding | |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | 4,697 | $5.22 | $24.5K | 296,084 −1.6% of holding | |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Sell | 1,641 | $5.20 | $8.5K | 188,671 −0.9% of holding | |
| Magrath George | Chief Executive Officer | Sell | 24,438 | $5.21 | $127.3K | 1,750,855 −1.4% of holding | |
| SCHACHLE JOSEPH K | Chief Operating Officer | Sell | 3,719 | $5.25 | $19.5K | 300,781 −1.2% of holding | |
| Jayagopal Ashwath | Chief Scientific & Dev. Ofc. | Sell | 3,719 | $5.12 | $19.0K | 516,775 −0.7% of holding | |
| Zaremba Rabourn Amy | Head of Fin. Quality Assurance | Sell | 2,816 | $5.25 | $14.8K | 190,312 −1.5% of holding | |
| Gallagher Cam 2 fills | Director | Buy | 164,000 | $1.97 | $323.7K | 1,891,430 | |
| Sell | 4,000,000 | $2.15 | $8.6M | 5,492,171 −42.1% of holding |
Form 4s are due within two business days of a transaction, so this is close to real time — unlike the quarterly 13F data on the Institutional tab. A single large sale often reflects a prearranged 10b5-1 plan rather than a fresh view, so read a pattern of sales rather than any one of them.